BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19689169)

  • 1. Armodafinil.
    Garnock-Jones KP; Dhillon S; Scott LJ
    CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
    J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE; Hull SG; Tiller J; Yang R; Harsh JR
    J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Armodafinil for excessive daytime sleepiness.
    Nishino S; Okuro M
    Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
    Keating GM; Raffin MJ
    CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T; Rippon GA; Arora S
    Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Armodafinil: a new treatment for excessive sleepiness.
    Lankford DA
    Expert Opin Investig Drugs; 2008 Apr; 17(4):565-73. PubMed ID: 18363520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
    Czeisler CA; Walsh JK; Wesnes KA; Arora S; Roth T
    Mayo Clin Proc; 2009 Nov; 84(11):958-72. PubMed ID: 19880686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder.
    Rosenberg RP; Bogan RK; Tiller JM; Yang R; Youakim JM; Earl CQ; Roth T
    Mayo Clin Proc; 2010 Jul; 85(7):630-8. PubMed ID: 20530317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Armodafinil in the treatment of excessive sleepiness.
    Bogan RK
    Expert Opin Pharmacother; 2010 Apr; 11(6):993-1002. PubMed ID: 20307223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M; Bond M; Ezzet F
    J Clin Pharmacol; 2012 Sep; 52(9):1328-42. PubMed ID: 22039290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR; Nelson MT; Schwartz ER; Hughes RJ
    Clin Neuropharmacol; 2004; 27(2):74-9. PubMed ID: 15252267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder.
    Erman MK; Seiden DJ; Yang R; Dammerman R
    J Occup Environ Med; 2011 Dec; 53(12):1460-5. PubMed ID: 22104981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.